<?xml version="1.0" encoding="UTF-8"?>
<p id="p0095">COLD-fX (CVT-E002), a poly-furanosyl-pyranosyl-saccharide isolated from the root of American ginseng, is believed to be safe, effective, and widely accepted as a therapeutic regimen against respiratory pathogens, reducing viral and bacterial load in patients of all ages, especially in patients who are more vulnerable to seasonal influenza-like illness [
 <xref rid="bib83" ref-type="bibr">83</xref>]. COLD-fX has been investigated as an immunomodulatory compound, acting through toll-like receptors. This activation leads to an increased number and function of cells within both the adaptive and innate immune systems [
 <xref rid="bib94" ref-type="bibr">94</xref>,
 <xref rid="bib95" ref-type="bibr">95</xref>].
</p>
